Market Cap

Enlivex Therapeutics Ltd. Market Capitalization:

₪557.4 Million

ILS as of Jan. 1, 2026

US$175.0 Million

business Enlivex Therapeutics Ltd. Company Profile

Enlivex Therapeutics Ltd. Main Stock Listing

TASE: ENLV

Market Capitalization History of Enlivex Therapeutics Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Enlivex Therapeutics Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 ₪557.4 M 543.39%
Jan. 1, 2025 ₪86.6 M -62.73%
Jan. 1, 2024 ₪232.4 M -11.34%
Jan. 1, 2023 ₪262.2 M -12.32%
Jan. 1, 2022 ₪299.0 M -58.22%
Jan. 1, 2021 ₪715.7 M 33.48%
Jan. 1, 2020 ₪536.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Enlivex Therapeutics Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

Enlivex Therapeutics Ltd. has the following listings and related stock indices.


Stock: TASE: ENLV

Stock: NASDAQ: ENLV

Stock: FSX: 1BT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.